Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial

  1. Gambacorti-Passerini, C.
  2. Brümmendorf, T.H.
  3. Abruzzese, E.
  4. Kelly, K.R.
  5. Oehler, V.G.
  6. García-Gutiérrez, V.
  7. Hjorth-Hansen, H.
  8. Ernst, T.
  9. Leip, E.
  10. Purcell, S.
  11. Luscan, G.
  12. Viqueira, A.
  13. Giles, F.J.
  14. Hochhaus, A.
Aldizkaria:
Leukemia

ISSN: 1476-5551,  0887-6924

Argitalpen urtea: 2024

Alea: 38

Zenbakia: 10

Orrialdeak: 2162-2170

Mota: Artikulua

DOI: 10.1038/S41375-024-02372-X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus